risk factors and seroprevalence of hepatitis b, c, and d virus in hemodialysis patients in istanbul

Clicks: 175
ID: 137679
2014
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Introduction: Hemodialysis units pose a risk for transmission of hepatitis viruses. In this study, we aimed to detect the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV) in our hospital’s hemodialysis unit and to determine the risk factors for transmission of hepatitis viruses. Materials and Methods: In Haydarpasa Numune Training and Research Hospital Hemodialysis Unit, hepatitis B surface antigen (HBsAg), hepatitis B core IgG antibody (anti-HBcIgG), hepatitis B surface antibody (anti-HBs), antibody to hepatitis C virus (anti- HCV), and anti-delta total were studied by enzyme-linked immunosorbent assay (ELISA) method in the serum samples of 50 hemodialysis patients. Risk factors for transmission of hepatitis virus were identified in hemodialysis patients. As a control group, 50 healthy individuals were included. Result: In hemodialysis patients, HBsAg was determined as 6% and anti-HCV as 28%, whereas anti-HDV positivity was not detected. HBsAg, anti-HBcIgG, and anti-HBs frequencies did not show statistically significant differences between the two groups, while anti-HCV frequency was found to be significantly higher in hemodialysis patients (p= 0.001). The mean age of HBsAg-positive hemodialysis patients was found significantly lower than that of HBsAg-negative hemodialysis patients (p= 0.045). Similarly, anti-HCV-positive hemodialysis patients had a statistically lower mean age compared to anti-HCV-negative hemodialysis patients (p< 0.004). Increase in hemodialysis duration and amount of blood transfusion were shown statistically to not affect anti-HBcIgG positivity. Anti-HCV positivity was found statistically significantly higher in patients undergoing hemodialysis for more than 10 years (p= 0.003). Conclusion: In hemodialysis patients, transmission of hepatitis viruses will decrease with promotion of the use of erythropoietin instead of blood transfusion and implementation of alternative methods of dialysis.
Reference Key
alp2014mediterraneanrisk Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;İnci ALP;Derya ÖZTÜRK ENGİN;Naz OĞUZOĞLU;Asuman İNAN;Nurgül CERAN;Nazım DENİZLİ;Seyfi ÖZYÜREK
Journal mediterranean journal of infection, microbes and antimicrobials
Year 2014
DOI 10.5578/mjima.6730
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.